机构:[1]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.台州恩泽医疗中心台州医院[2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China四川大学华西医院[3]Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China台州恩泽医疗中心台州医院
Dear Editor, Bladder cancer (BLCA) is reported as one of the most common genitourinary malignancies which usually occurs in elderly people.1 There is a critical clinical need for biomarkers that can precisely predict patient outcomes and responses to treatments in the current era of precision oncology. In our research, we initially investigate the impact of DMRT1 on BLCA patients using bioinformatic analysis, using methodologies detailed in our prior study.
基金:
Zhejiang Province Public Welfare Technology Application Research Project in China (TGY23H160090, LGF21H160029); Taizhou Science and Technology Project, Zhejiang Province (20ywb12); Traditional Chinese medicine of Zhejiang province science and technology plan project(2020ZB293) and Chinese Scholarship Council (grant no.202206240086).
第一作者机构:[1]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
共同第一作者:
通讯作者:
通讯机构:[2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China[3]Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China
推荐引用方式(GB/T 7714):
Ye Luxia,Lu Lingxiao,Feng Dechao,et al.DMRT1 could serve as a prognostic biomarker for bladder cancer patients[J].Asian Journal Of Surgery.2024,47(11):4968-4970.doi:10.1016/j.asjsur.2024.05.218.
APA:
Ye Luxia,Lu Lingxiao,Feng Dechao&Ke Mang.(2024).DMRT1 could serve as a prognostic biomarker for bladder cancer patients.Asian Journal Of Surgery,47,(11)
MLA:
Ye Luxia,et al."DMRT1 could serve as a prognostic biomarker for bladder cancer patients".Asian Journal Of Surgery 47..11(2024):4968-4970